Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
January 9, 2023 8-K

Report of unscheduled material events or corporate event

0001193125-23-004217.pdf
0001193125-23-004217.rtf
0001193125-23-004217.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 9, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-22-023819.pdf
0000950170-22-023819.rtf
0000950170-22-023819.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 17, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-263368.pdf
0001193125-22-263368.rtf
0001193125-22-263368.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 12, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-261037.pdf
0001193125-22-261037.rtf
0001193125-22-261037.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 12, 2022 3

Initial filing by director officer or owner of more than ten percent.

0000899243-22-033451.pdf
0000899243-22-033451.rtf
0000899243-22-033451.xls
View HTML
October 12, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-033453.pdf
0000899243-22-033453.rtf
0000899243-22-033453.xls
View HTML
October 12, 2022 3

Initial filing by director officer or owner of more than ten percent.

0000899243-22-033483.pdf
0000899243-22-033483.rtf
0000899243-22-033483.xls
View HTML
September 20, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-247407.pdf
0001193125-22-247407.rtf
0001193125-22-247407.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 13, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-243305.pdf
0001193125-22-243305.rtf
0001193125-22-243305.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-22-016440.pdf
0000950170-22-016440.rtf
0000950170-22-016440.xls
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 119 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us